Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Westin

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Haematologica|March 31, 2015
Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphomaYasuhiro Oki, Anas Younes, Javier Knickerbocker, et al.
Annals of Hematology|December 31, 2013
Accelerated therapeutic progress in diffuse large B cell lymphomaQingqing Cai, Jason Westin, Kai Fu, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 29, 2021
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaJason Westin, Michael B Maris, Caron A Jacobson, et al.
Leukemia & Lymphoma|April 27, 2018
Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure<sup/>Ethan B Ludmir, Sarah A Milgrom, Chelsea C Pinnix, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2019
Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid TissueEthan B Ludmir, Sarah A Milgrom, Chelsea C Pinnix, et al.
The Lancet. Haematology|October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 studySarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2022
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib StudyMaria Lia Palomba, Guillaume Cartron, Leslie Popplewell, et al.
Neuro-Oncology Advances|March 24, 2020
Primary CNS lymphoma commonly expresses immune response biomarkersAlexander Ou, Ashley Sumrall, Surasak Phuphanich, et al.
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.
British Journal of Haematology|November 5, 2020
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapyPreetesh Jain, Loretta Nastoupil, Jason Westin, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Haematologica|March 31, 2015
Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphomaYasuhiro Oki, Anas Younes, Javier Knickerbocker, et al.
Annals of Hematology|December 31, 2013
Accelerated therapeutic progress in diffuse large B cell lymphomaQingqing Cai, Jason Westin, Kai Fu, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 29, 2021
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaJason Westin, Michael B Maris, Caron A Jacobson, et al.
Leukemia & Lymphoma|April 27, 2018
Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure<sup/>Ethan B Ludmir, Sarah A Milgrom, Chelsea C Pinnix, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2019
Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid TissueEthan B Ludmir, Sarah A Milgrom, Chelsea C Pinnix, et al.
The Lancet. Haematology|October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 studySarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2022
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib StudyMaria Lia Palomba, Guillaume Cartron, Leslie Popplewell, et al.
Neuro-Oncology Advances|March 24, 2020
Primary CNS lymphoma commonly expresses immune response biomarkersAlexander Ou, Ashley Sumrall, Surasak Phuphanich, et al.
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.
British Journal of Haematology|November 5, 2020
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapyPreetesh Jain, Loretta Nastoupil, Jason Westin, et al.
Pageof 10